I agree that this site is using cookies. You can find further informations here.
X
Okusanya, Olanrewaju O.
76  results:
Search for persons X
?
1

FDA Approval Summary: Selinexor for Relapsed or Refractory ..:

Kasamon, Yvette L. ; Price, Lauren S.L. ; Okusanya, Olanrewaju O....
The Oncologist.  26 (2021)  10 - p. 879-886 , 2021
Link: https://doi.org/10.1002/..
 
?
2

A Simulation Approach to Evaluate the Impact of Patterns of..:

Obianom, Obinna N. ; Okusanya, Olanrewaju O. ; Earp, Justin.
Clinical Pharmacology & Therapeutics.  108 (2020)  1 - p. 107-115 , 2020
Link: https://doi.org/10.1002/..
 
?
3

Application of Pharmacokinetic-Pharmacodynamic Modeling and..:

Tsuji, Brian T. ; Okusanya, Olanrewaju O. ; Bulitta, Jurgen B....
Clinical Infectious Diseases.  52 (2011)  - p. S513-S519 , 2011
Link: https://www.jstor.org/st..
 
?
4

Evaluation of the pharmacokinetics–pharmacodynamics of fusi..:

Okusanya, Olanrewaju O. ; Tsuji, Brian T. ; Bülitta, Jurgen B....
Diagnostic Microbiology and Infectious Disease.  70 (2011)  1 - p. 101-111 , 2011
Link: https://doi.org/10.1016/..
 
?
5

Application of Pharmacokinetic-Pharmacodynamic Modeling and..:

Tsuji, Brian T. ; Okusanya, Olanrewaju O. ; Bulitta, Jurgen B....
Clinical Infectious Diseases.  52 (2011)  suppl_7 - p. S513-S519 , 2011
Link: https://doi.org/10.1093/..
 
?
6

Use of pharmacodynamic endpoints for the evaluation of levo..:

Ambrose, Paul G. ; Anon, Jack B. ; Bhavnani, Sujata M....
Diagnostic Microbiology and Infectious Disease.  61 (2008)  1 - p. 13-20 , 2008
Link: https://doi.org/10.1016/..
 
?
7

FDA Approval Summary: Belumosudil For Adult and Pediatric P..:

Przepiorka, Donna ; Le, Robert Q ; Ionan, Alexei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197942/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

FDA Approval Summary: Belantamab Mafodotin for Patients wit..:

Baines, Andrea C ; Ershler, Rachel ; Kanapuru, Bindu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633344/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

FDA approval summary: decitabine and cedazuridine tablets f..:

Kim, Nina ; Norsworthy, Kelly J ; Subramaniam, Sriram...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378483/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

FDA Approval Summary: Revised Indication and Dosing Regimen..:

Pulte, E Dianne ; Chen, Haiyan ; Price, Lauren S L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895737/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin a..:

Bulik, Catharine C ; Okusanya, Ólanrewaju O ; Lakota, Elizabeth A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278741/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
12

Exploration of the Pharmacokinetic-Pharmacodynamic Relation..:

VanScoy, Brian D ; McCauley, Jennifer ; Ellis-Grosse, Evelyn J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649205/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
13

Evaluation of the Pharmacokinetics and Pharmacodynamics of ..:

Okusanya, Olanrewaju O ; Bhavnani, Sujata M ; Hammel, Jeffrey P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
14

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics..:

VanScoy, Brian ; Mendes, Rodrigo E ; McCauley, Jennifer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
15

Relationship between Ceftolozane-Tazobactam Exposure and Dr..:

VanScoy, Brian ; Mendes, Rodrigo E ; Castanheira, Mariana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754319.  , 2013
Link: http://www.ncbi.nlm.nih...
 
1-15